Affinity Asset Advisors, LLC Seagen Inc. Transaction History

Affinity Asset Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $1.92 Million - $2.16 Million	10,000 New	10,000 $2.12 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $1.91 Million - $3.05 Million	15,000 Added 300.0%	20,000 $4.05 Million
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $586,850 - $695,849	5,000 New	5,000 $642,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.